About 30 results found for searched term "EP2" (0.012 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1859 | RepSox (ALK5 Inhibitor II) | ALK |
| RepSox; E-616452; SJN 2511; 616452 | ||
| RepSox (ALK5 Inhibitor II) is a potent and ATP-competitive inhibitor of the TGF-β type I receptor ALK5 (IC50 values are 0.004 and 0.023 μM for ALK5 autophosphorylation and ALK5 binding respectively). | ||
| M1908 | VER-82576 | HSP |
| NVP-BEP800; VER82576 | ||
| VER-82576 (NVP-BEP800) is a potent, orally available and selective inhibitor of Hsp90β with an IC50 of 58 nM. VER-82576 also slightly blocks Grp94 and Trap-1, with IC50s of 4.1 and 5.5 μM, respectively. | ||
| M1946 | CEP-28122 | ALK |
| CEP-28122 is a highly potent and selective orally active ALK inhibitor. | ||
| M2007 | Romidepsin (FK228) | HDAC |
| FK228; ISTODAX; Depsipeptide; FR 901228; NSC 630176 | ||
| Romidepsin (FK228, Depsipeptide, FR 901228, NSC 630176) is a structurally unique, potent HDAC1 and HDAC2 inhibitor with IC50 of 36 nM and 47 nM, respectively.*The compound is unstable in solutions, freshly prepared is recommended | ||
| M2045 | CEP-32496 | Raf |
| RXDX-105; Agerafenib | ||
| CEP-32496 is a potent orally active BRAF inhibitor with IC50 of 14 nM. | ||
| M11162 | Pep2-8 | PCSK9 |
| Pep2-8 is a PCSK9 inhibitor, of which KD The value is 0.7 μM,IC50 The value is 1.4 μM. | ||
| M3274 | Pentagastrin | Cholecystokinin Receptor |
| Peptavlon; ICI-50123 | ||
| Pentagastrin (ICI-50123) is a synthetic polypeptide that has effects like gastrin when given parenterally. | ||
| M3357 | Telbivudine | Anti-infection |
| Epavudine; L-Thymidine; NV 02B | ||
| Telbivudine (Epavudine) is an orally active, potent antiviral inhibitor of hepatitis B virus (HBV) replication. Telbivudine is an antiviral compound used in hepatitis B research. | ||
| M3447 | PF-2545920 | PDE |
| Mardepodect; CAS# 898562-94-2 | ||
| PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with >1000-fold selectivity over the PDE. | ||
| M3539 | Verteporfin (CL 318952) | YAP |
| CL 318952; BPD-MA | ||
| Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin (CL 318952) is a YAP inhibitor that disrupts YAP-TEAD interactions, and it is also an inhibitor of autophagy. | ||
| M3624 | Boceprevir (EBP 520) | HCV Protease |
| EBP-520, SCH503034 | ||
| Boceprevir (EBP-520, SCH503034) is an HCV protease inhibitor (Ki=14 nM) for the treatment of hepatitis C virus infection. | ||
| M1555 | Amyloid β-Peptide (1-42) human,TFA | Amyloid |
| Aβ1-42; β-Amyloid (1-42) | ||
| Amyloid β-Peptide (1-42) is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease. | ||
| M5229 | EPZ020411 | PRMTs |
| EPZ-020411 | ||
| EPZ020411 is a potent and selective inhibitor of PRMT6 with IC50 of 10 nM, has ＞10 fold selectivity for PRMT6 over PRMT1 and PRMT8. | ||
| M58149 | Recombinant Vaccinia virus B18R (HEK293, C-6His) | Cytokines and Growth Factors |
| Soluble interferon alpha/beta receptor B18; VACWR200 | ||
| B18R is a type I interferon (IFN)-binding protein encoded by the B18R open reading frame in the Western Reserve strain of vaccinia virus. B18R has high affinity for human IFN-alpha and also binds rabbit, bovine, rat, pig, and mouse IFN-alpha and IFN-beta. Secreted B18R binds to uninfected and infected cells. B18R presents at the cell surface and protects cells from the antiviral state. | ||
| M5360 | 2-Aminoheptane | Others |
| Tuaminoheptanez, Tuamine, Heptamine, 1-Methylhexylamine, 2-Heptylamine | ||
| 2-Aminoheptane is a nasal decongestant drug which is a sympathomimetic stimulant and vasoconstrictor. | ||
| M6278 | Epothilone D | Microtubule |
| 12,13-Desoxyepothilone B; Desoxyepothilone B; KOS 862 | ||
| Epothilone D is a potent microtubule stabilizer. | ||
| M7439 | U-46619 | Others |
| 9,11-Methanoepoxy PGH2 | ||
| U-46619 is a pGH2 (TXA2) analog that is a potent and stable thromboxane A2 (TP) receptor agonist (EC50 = 0.035 μM). U-46619 potently stimulates TP receptor-mediated, but not other prostaglandin receptor-mediated responses in various in vitro preparations. | ||
| M8825 | Adenosine A1 receptor activator T62 | Adenosine Receptor |
| Adenosine A1 receptor activator T62 is an allosteric enhancer of adenosine A1 receptor. | ||
| M9001 | ML-265 (TEPP-46) | Pyruvate Kinase |
| TEPP-46; ML265 | ||
| Ml-265 (TEPP-46) is an effective activator of pyruvate kinase M2 (PKM2). | ||
| M9010 | Crolibulin | Microtubule |
| EPC2407; crinobulin | ||
| Crolibulin (also known as EPC2407 and crinobulin) is a small molecule tubulin polymerization inhibitor with potential antineoplastic activity. | ||
| M9071 | Amyloid beta-peptide(25-35) | Amyloid |
| Aβ25-35; β-Amyloid peptide(25-35) | ||
| Amyloid beta-peptide(25-35) is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide, has shown neurotoxic activities in cultured cells. | ||
| M9420 | GSK3326595 | PRMTs |
| EPZ015938; GSK-3326595 | ||
| GSK3326595 is a potent, reversible and selective protein arginine methyltransferase 5 (PRMT5) inhibitor with broad antiproliferative activity for studies related to lymphoma and leukemia. | ||
| M10233 | ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | Neuropeptide Receptor |
| BWX 46 | ||
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2, also called BWX 46, is a neuropeptide Y (NPY) Y5 receptor selective agonist. | ||
| M10235 | SLIGRL-NH2 | PAR |
| Protease-Activated Receptor-2 Activating Peptide | ||
| SLIGRL-NH2 (Protease-Activated Receptor-2 Activating Peptide) is an agonist of Protease-Activated Receptor-2 (PAR-2). | ||
| M10237 | Protease-Activated Receptor-2, amide | PAR |
| SLIGKV-NH2 | ||
| Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent agonist of PAR2 with IC50 of 10.4 uM. | ||
| M10247 | Nesiritide acetate | Peptides |
| natriureticpeptide; BNP-32; 124584-08-3 | ||
| Nesiritide acetate is an agonist of natriuretic peptide receptors (NPRs), with Kd values of 7.3 and 13 pM for NPR-A and NPR-C, respectively. | ||
| M10358 | C-Type Natriuretic Peptide (CNP) (1-22), human | Angiotensin Receptor |
| CNP-22, human | ||
| C-Type Natriuretic Peptide (CNP) (1-22), human is the 1-22 fragment of C-Type Natriuretic Peptide. | ||
| M10427 | OVA Peptide (257-264) TFA | Peptides |
| OVA Peptide (257-264) TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb. | ||
| M10489 | NEO2734 (EP31670) | Epigenetic Reader Domain |
| EP31670; NEO-2734 | ||
| NEO2734 (EP31670) is a novel, orally active and selective dual inhibitor of p300/CBP and BET bromodomain with IC50 of both <30 nM. | ||
| M10637 | GSK3368715 2HCl | PRMTs |
| EPZ019997 2HCl | ||
| GSK3368715 2HCl is a novel potent, orally active, reversible type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50 values of 3.1 nM, 48 nM, 1148 nM, 5.7 nM and 1.7 nM for PRMT1, PRMT3, PRMT4, PRMT6, PRMT8, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
